Dechert Advises NAMSA on Strategic Acquisition of WuXi AppTec's U.S. Medical Device ...

Retrieved on: 2025-01-17 18:31:29

Tags for this article:

Click the tags to see associated articles and topics

Dechert Advises NAMSA on Strategic Acquisition of WuXi AppTec's U.S. Medical Device .... View article details on hiswai:

Summary

Dechert advised NAMSA, a MedTech firm, on acquiring WuXi AppTec's U.S. device testing operations. This strategic move enhances NAMSA's MedTech capabilities amid regulatory challenges. The transaction highlights the roles of WuXi AppTec and Dechert in the MedTech sector.

Article found on: www.dechert.com

View Original Article